Bcl-2 Inhibition Induces a Synergistic Effect in Combination with Doxorubicin in Chronic Lymphocytic Leukemia
Background: Chronic lymphocytic leukemia (CLL), a common neoplastic disease, is associated with the accumulation of B-lymphocytes in the hematopoietic organs. A main characteristic of CLL cells is the failure to undergo apoptosis, thus resulting in resistance to several chemotherapeutics. Doxorubici...
Main Authors: | Mohammad Sadeghi, Koosha Sepasi, Amir Honarmand Alamdari, Ali Akbar Movasaghpour Akbari, Abbas Ali Hosseinpour Feizi, Sima Shahmohammadi Farid, Farhad Jadidi-Niaragh |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2022-12-01
|
Series: | ImmunoAnalysis |
Subjects: | |
Online Access: | https://ia.tbzmed.ac.ir/PDF/ia-2-14.pdf |
Similar Items
-
Blockade of CD73 Increases the Cytotoxic Effects of Fludarabine in Chronic Lymphocytic Leukemia
by: Mohammad Sadeghi, et al.
Published: (2022-12-01) -
Silencing of mTOR Facilitates the Cyclophosphamide-Mediated Cytotoxicity in Acute Lymphoblastic Leukemia
by: Mohammad Sadeghi, et al.
Published: (2023-03-01) -
Polyethylenimine-Conjugated Hydroxyethyl Cellulose for Doxorubicin/Bcl-2 siRNA Co-Delivery Systems
by: Jiwon Park, et al.
Published: (2023-02-01) -
Combinational Therapy of Acute Lymphoblastic Leukemia with Cyclophosphamide and BV6 Synergistically Induces Apoptosis in Leukemic Cells
by: Mohammad Sadeghi, et al.
Published: (2022-12-01) -
Evaluation of Bcl 2 and Ki 67 expression in Chronic Lymphocytic Leukemia .
by: Subh S. AL- Mudallal, et al.
Published: (2013-01-01)